fax: +34 946015662
Steatohepatitis/Metabolic Liver Disease
Article first published online: 30 NOV 2011
Copyright © 2011 American Association for the Study of Liver Diseases
Volume 54, Issue 6, pages 1975–1986, December 2011
How to Cite
Cano, A., Buqué, X., Martínez-Uña, M., Aurrekoetxea, I., Menor, A., García-Rodríguez, J. L., Lu, S. C., Martínez-Chantar, M. L., Mato, J. M., Ochoa, B. and Aspichueta, P. (2011), Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice. Hepatology, 54: 1975–1986. doi: 10.1002/hep.24607
Potential conflict of interest: Nothing to report.
This work was supported by the Basque Government IT-336-10 (to B.O. and P.A.) and Ministerio de Educación SAF2007-60211 (to B.O. and P.A.), US National Institutes of Health AT-1576 (to S.C.L., M.L.M-C. and J.M.M.), SAF2008-04800 (to M.L.M-C. and J.M.M.), and Etortek bioGUNE 2008 IE08-228 (to P.A and M.L.M-C). A.C. was a recipient of a predoctoral fellowship from the University of the Basque Country and was awarded the National Investigation prize “Juan Abelló Pascual” from the Royal Academy of Doctors of Spain (RADE).
- Issue published online: 30 NOV 2011
- Article first published online: 30 NOV 2011
- Accepted manuscript online: 11 AUG 2011 09:28AM EST
- Manuscript Accepted: 26 JUL 2011
- Manuscript Received: 8 APR 2011
Very low-density lipoprotein (VLDL) secretion provides a mechanism to export triglycerides (TG) from the liver to peripheral tissues, maintaining lipid homeostasis. In nonalcoholic fatty liver disease (NAFLD), VLDL secretion disturbances are unclear. Methionine adenosyltransferase (MAT) is responsible for S-adenosylmethionine (SAMe) synthesis and MAT I and III are the products of the MAT1A gene. Deficient MAT I and III activities and SAMe content in the liver have been associated with NAFLD, but whether MAT1A is required for normal VLDL assembly remains unknown. We investigated the role of MAT1A on VLDL assembly in two metabolic contexts: in 3-month-old MAT1A-knockout mice (3-KO), with no signs of liver injury, and in 8-month-old MAT1A-knockout mice (8-KO), harboring nonalcoholic steatohepatitis. In 3-KO mouse liver, there is a potent effect of MAT1A deletion on lipid handling, decreasing mobilization of TG stores, TG secretion in VLDL and phosphatidylcholine synthesis via phosphatidylethanolamine N-methyltransferase. MAT1A deletion also increased VLDL– apolipoprotein B secretion, leading to small, lipid-poor VLDL particles. Administration of SAMe to 3-KO mice for 7 days recovered crucial altered processes in VLDL assembly and features of the secreted lipoproteins. The unfolded protein response was activated in 8-KO mouse liver, in which TG accumulated and the phosphatidylcholine-to-phosphatidylethanolamine ratio was reduced in the endoplasmic reticulum, whereas secretion of TG and apolipoprotein B in VLDL was increased and the VLDL physical characteristics resembled that in 3-KO mice. MAT1A deletion also altered plasma lipid homeostasis, with an increase in lipid transport in low-density lipoprotein subclasses and decrease in high-density lipoprotein subclasses. Conclusion:MAT1A is required for normal VLDL assembly and plasma lipid homeostasis in mice. Impaired VLDL synthesis, mainly due to SAMe deficiency, contributes to NAFLD development in MAT1A-KO mice. (HEPATOLOGY 2011